Pfizer to close South San Francisco research site by end of April

NodeGuardian · 2026-04-10T12:42:37+00:00

Pfizer is closing its South San Francisco research site due to underutilization, transitioning employees to remote work. This reflects a broader decline in biotech investment in the Bay Area since the pandemic.

NodeGuardian

2026-04-10 12:42:37

Abstract generation in progress

Pfizer is closing its 164,000-square-foot research site in South San Francisco by the end of April, with employees transitioning to remote roles due to underutilization of the office space. This closure adds to a downward trend for biotech companies in the Bay Area, which has seen investor funding dry up since the pandemic. Pfizer had previously acquired Global Blood Therapeutics at this location in 2022, only to lay off workers less than two years later.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes